Endo Health Solutions

NASDAQ: ENDP
$3.18
+$0.09 (+2.9%)
Closing price April 3, 2020
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Jon C. Ogg
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Jon C. Ogg
Five drugmakers are considering a proposal that would have them contribute to a trust established as part of the bankruptcy settlement by Purdue Pharmaceuticals and be released from liability in the...
Paul Ausick
Endo shares jumped on Friday after the company announced that it has submitted a Biologics License Application to the FDA for collagenase clostridium histolyticum for the treatment of cellulite in...
Chris Lange
Shares of drugmaker Mallinckrodt have lost more than 40% overnight following reports that the firm has hired restructuring advisors. A bankruptcy filing is a real possibility.
Paul Ausick
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
Jon C. Ogg
Tuesday was a breakout day for a few biotech companies that saw either huge gains or massive losses. 24/7 Wall St. has picked a few of those standouts to highlight.
Chris Lange
Endo International announced on Tuesday that its Endo and Par Pharma subsidiaries have reached a settlement in principle with the Cuyahoga and Summit counties in Ohio.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Thursday included Allstate, Bed Bath & Beyond, Best Buy, Blue Apron, Costco Wholesale, Home Depot, Microsoft, Take-Two Interactive...
Jon C. Ogg
Stocks were indicated to open marginally higher on Monday after gains of about 0.4% for the Dow and S&P 500 last week. This summer Monday is not seeing any vast amounts of new news rattling the...
Jon C. Ogg
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
Jon C. Ogg
These are five stocks for very aggressive accounts looking to get share-count leverage on companies that have sizable upside potential.
Lee Jackson
The top analyst upgrades, downgrades and initiations seen on Monday included Alarm.com, Exxon Mobil, Goldman Sachs BDC, Merck, Pinterest, Shopify, Wendy's and Zoom Video Communications.
Jon C. Ogg
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra Energy, Peabody Energy, Teva Pharmaceutical and...
Jon C. Ogg
24/7 Wall St. tracked 10 companies seeing three or more analyst rating upgrades or price target hikes on Thursday, August 9, 2018.
Jon C. Ogg